ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, featuring promising developments throughout several medical and industrial applications. With its structural similarity to Normally derived human serum albumin, OsrHSA gives a safer, additional dependable alternate for therapeutic use, part